» Articles » PMID: 34202490

Age-Dependent Hippocampal Proteomics in the APP/PS1 Alzheimer Mouse Model: A Comparative Analysis with Classical SWATH/DIA and DirectDIA Approaches

Overview
Journal Cells
Publisher MDPI
Date 2021 Jul 2
PMID 34202490
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD) is the most common neurodegenerative disorder in the human population, for which there is currently no cure. The cause of AD is unknown; however, the toxic effects of amyloid-β (Aβ) are believed to play a role in its onset. To investigate this, we examined changes in global protein levels in a hippocampal synaptosome fraction of the Amyloid Precursor Protein swe/Presenelin 1 dE9 (APP/PS1) mouse model of AD at 6 and 12 months of age (moa). Data independent acquisition (DIA), or Sequential Window Acquisition of all THeoretical fragment-ion (SWATH), was used for a quantitative label-free proteomics analysis. We first assessed the usefulness of a recently improved directDIA workflow as an alternative to conventional DIA data analysis using a project-specific spectral library. Subsequently, we applied directDIA to the 6- and 12-moa APP/PS1 datasets and applied the Mass Spectrometry Downstream Analysis Pipeline (MS-DAP) for differential expression analysis and candidate discovery. We observed most regulation at 12-moa, in particular of proteins involved in Aβ homeostasis and microglial-dependent processes, like synaptic pruning and the immune response, such as APOE, CLU and C1QA-C. All proteomics data are available via ProteomeXchange with identifier PXD025777.

Citing Articles

Muscle Cathepsin B treatment improves behavioral and neurogenic deficits in a mouse model of Alzheimer's Disease.

Pinto A, Haytural H, Loss C, Loss C, Alvarez C, Ertas A bioRxiv. 2025; .

PMID: 39896474 PMC: 11785056. DOI: 10.1101/2025.01.20.633414.


Suppressing UBE2N ameliorates Alzheimer's disease pathology through the clearance of amyloid beta.

Zhang C, Jia Q, Zhu L, Hou J, Wang X, Li D Alzheimers Dement. 2024; 20(9):6287-6304.

PMID: 39015037 PMC: 11497675. DOI: 10.1002/alz.14122.


The mouse multi-organ proteome from infancy to adulthood.

Wang Q, Ding X, Xu Z, Wang B, Wang A, Wang L Nat Commun. 2024; 15(1):5752.

PMID: 38982135 PMC: 11233712. DOI: 10.1038/s41467-024-50183-6.


Updates on mouse models of Alzheimer's disease.

Zhong M, Peng T, Duarte M, Wang M, Cai D Mol Neurodegener. 2024; 19(1):23.

PMID: 38462606 PMC: 10926682. DOI: 10.1186/s13024-024-00712-0.


Early-life stress and amyloidosis in mice share pathogenic pathways involving synaptic mitochondria and lipid metabolism.

Kotah J, Kater M, Brosens N, Lesuis S, Tandari R, Blok T Alzheimers Dement. 2023; 20(3):1637-1655.

PMID: 38055782 PMC: 10984508. DOI: 10.1002/alz.13569.


References
1.
Pandya N, Koopmans F, Slotman J, Paliukhovich I, Houtsmuller A, Smit A . Correlation profiling of brain sub-cellular proteomes reveals co-assembly of synaptic proteins and subcellular distribution. Sci Rep. 2017; 7(1):12107. PMC: 5608747. DOI: 10.1038/s41598-017-11690-3. View

2.
de Silva H, Stuart W, Duvic C, Wetterau J, Ray M, Ferguson D . A 70-kDa apolipoprotein designated ApoJ is a marker for subclasses of human plasma high density lipoproteins. J Biol Chem. 1990; 265(22):13240-7. View

3.
Li S, Selkoe D . A mechanistic hypothesis for the impairment of synaptic plasticity by soluble Aβ oligomers from Alzheimer's brain. J Neurochem. 2020; 154(6):583-597. PMC: 7487043. DOI: 10.1111/jnc.15007. View

4.
Wan Y, Al-Ouran R, Mangleburg C, Perumal T, Lee T, Allison K . Meta-Analysis of the Alzheimer's Disease Human Brain Transcriptome and Functional Dissection in Mouse Models. Cell Rep. 2020; 32(2):107908. PMC: 7428328. DOI: 10.1016/j.celrep.2020.107908. View

5.
Vegh M, Heldring C, Kamphuis W, Hijazi S, Timmerman A, Li K . Reducing hippocampal extracellular matrix reverses early memory deficits in a mouse model of Alzheimer's disease. Acta Neuropathol Commun. 2014; 2:76. PMC: 4149201. DOI: 10.1186/s40478-014-0076-z. View